Oral octreotide for treatment of disease
OwnerAsi HAVIVinventor
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treating one or more symptoms associated with neuroendocrine tumors, such as diarrhea and flushing episodes associated with carcinoid tumors and methods of treating carcinoid syndrome, comprising orally administering compositions comprising octreotide or a pharmaceutically acceptable salt thereof.
Claims72
A method for treating diarrhea and flushing episodes associated with carcinoid tumors in a patient in need thereof, comprising orally administering a total daily dose of at least about 120 mg of octreotide or a pharmaceutically acceptable salt thereof to the patient.
A method of treating carcinoid syndrome in a patient in need thereof comprising orally administering a total daily dose of at least about 120 mg of octreotide or a pharmaceutically acceptable salt thereof to the patient.
Dependencies are inferred from the claim text.